Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Sutcliffe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Cellular Biochemistry|January 1, 1983
Expression and regulation of protein K, an Escherichia coli K1 porin, in Escherichia coli K-12J A Sutcliffe, J D Foulds
Antimicrobial Agents and Chemotherapy|January 1, 1990
Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systemsT D Gootz, J F Barrett, J A Sutcliffe
Antimicrobial Agents and Chemotherapy|January 1, 1990
In vitro assays used to measure the activity of topoisomerasesJ F Barrett, J A Sutcliffe, T D Gootz
Antimicrobial Agents and Chemotherapy|December 1, 1989
Biochemical characteristics and physiological significance of major DNA topoisomerasesJ A Sutcliffe, T D Gootz, J F Barrett
Antimicrobial Agents and Chemotherapy|August 28, 2013
Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogensJ A Sutcliffe, W O'Brien, C Fyfe, et al.
The Journal of Biological Chemistry|August 5, 1991
Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavageM J Robinson, B A Martin, T D Gootz, et al.
The Journal of Antibiotics|February 1, 1995
CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors. Fermentation,isolation, structural elucidation and biological activitiesS Sakemi, T Inagaki, K Kaneda, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1994
In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobialT D Gootz, K E Brighty, M R Anderson, et al.
The Journal of Antibiotics|April 17, 1998
CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation, structure elucidation and biological activitiesT Inagaki, K Kaneda, Y Suzuki, et al.
Clinical Radiology|December 3, 2014
Antibiotics in interventional radiologyJ A Sutcliffe, J H Briggs, M W Little, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|January 1, 1983
Expression and regulation of protein K, an Escherichia coli K1 porin, in Escherichia coli K-12J A Sutcliffe, J D Foulds
Antimicrobial Agents and Chemotherapy|January 1, 1990
Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systemsT D Gootz, J F Barrett, J A Sutcliffe
Antimicrobial Agents and Chemotherapy|January 1, 1990
In vitro assays used to measure the activity of topoisomerasesJ F Barrett, J A Sutcliffe, T D Gootz
Antimicrobial Agents and Chemotherapy|December 1, 1989
Biochemical characteristics and physiological significance of major DNA topoisomerasesJ A Sutcliffe, T D Gootz, J F Barrett
Antimicrobial Agents and Chemotherapy|August 28, 2013
Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogensJ A Sutcliffe, W O'Brien, C Fyfe, et al.
The Journal of Biological Chemistry|August 5, 1991
Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavageM J Robinson, B A Martin, T D Gootz, et al.
The Journal of Antibiotics|February 1, 1995
CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors. Fermentation,isolation, structural elucidation and biological activitiesS Sakemi, T Inagaki, K Kaneda, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1994
In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobialT D Gootz, K E Brighty, M R Anderson, et al.
The Journal of Antibiotics|April 17, 1998
CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation, structure elucidation and biological activitiesT Inagaki, K Kaneda, Y Suzuki, et al.
Clinical Radiology|December 3, 2014
Antibiotics in interventional radiologyJ A Sutcliffe, J H Briggs, M W Little, et al.
Pageof 2